Literature DB >> 6714268

Comparative pharmacokinetics of 14C-piperacillin following intravenous and intraperitoneal administration in pregnant and non-pregnant rats.

V Batra, J Morrison, E Kaleita.   

Abstract

14C-piperacillin (Pipracil) at a dose level of 1000 mg/kg was administered intravenously or intraperitoneally to pregnant and non-pregnant female rats. Rats were sacrificed at predetermined time intervals, and 14C-piperacillin concentrations determined in serum, amniotic fluid, placenta, and fetus. The piperacillin serum levels in both pregnant and nonpregnant rats following intravenous administration were comparable; however, following intraperitoneal administration, the serum drug levels in the pregnant rats as compared to the nonpregnant rats were lower. The fetal drug levels, however, were higher following intraperitoneal administration than following intravenous administration. The total area under the fetal drug concentration-time curve following intraperitoneal administration was about two times the corresponding area under the curve following intravenous administration. The data indicate that the fetal exposure to piperacillin was greater following intraperitoneal administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6714268     DOI: 10.1007/BF03189603

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Pharmacokinetics of ampicillin during pregnancy.

Authors:  A Philipson
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

2.  In vitro and in vivo activity of piperacillin, a new broad-spectrum semisynthetic penicillin.

Authors:  N A Kuck; G S Redin
Journal:  J Antibiot (Tokyo)       Date:  1978-11       Impact factor: 2.649

3.  Piperacillin kinetics.

Authors:  V K Batra; J A Morrison; K C Lasseter; V A Joy
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

  3 in total
  1 in total

1.  Species differences in pharmacokinetics and drug teratogenesis.

Authors:  H Nau
Journal:  Environ Health Perspect       Date:  1986-12       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.